Concepedia

Natalie Wu

NW

Statistics

Publications

4

Citations

124

H-Index

4

Active since

2017

Affiliations

Tokyo Medical University Ibaraki Medical Center(Current)

Natalie Wu is an author at Tokyo Medical University Ibaraki Medical Center specializing in medicine, cancer biomarkers, and molecular oncology.

Publications per year

2017–2021

4

Publications

4

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

Natalie Wu, Wendy Wong, Kenneth Ho et al. · Breast Cancer Research and Treatment · 2018 · 54 citations · Full text

, , +17

High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence

Brad Wasserman, Daniel Carvajal‐Hausdorf, Kenneth Ho et al. · Laboratory Investigation · 2017 · 27 citations · Full text

, , +17

ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6

Martin Filipits, Margaretha Rudas, Christian F. Singer et al. · ESMO Open · 2021 · 24 citations · Full text

, , +17

Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country

Marcellin C. Mugabe, Kenneth Ho, Déogratias Ruhangaza et al. · American Journal of Clinical Pathology · 2021 · 19 citations · Full text

, , +16

1–4 of 4